Kamila Kaminska

If you made any changes in Pure these will be visible here soon.

2021
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Alves, C. L., Ehmsen, S., Terp, M. G., Portman, N., Tuttolomondo, M., Gammelgaard, O. L., Hundebøl, M. F., Kaminska, K., Johansen, L. E., Bak, M., Honeth, G., Bosch, A., Lim, E. & Ditzel, H. J., 2021 Dec, In: Nature Communications. 12, 1, 5112.
Research output: Contribution to journal › Article › peer-review

Open Access
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, K., Akrap, N., Staaf, J., Alves, C. L., Ehinger, A., Ebbesson, A., Hedenfalk, I., Beumers, L., Veerla, S., Harbst, K., Ehmsen, S., Borgquist, S., Borg, Å., Pérez-Fidalgo, A., Ditzel, H. J., Bosch, A. & Honeth, G., 2021 Feb 18, In: Breast cancer research : BCR. 23, 1, p. 26
Research output: Contribution to journal › Article › peer-review

Open Access

Research output